The global cell isolation/cell separation market is valued at USD 4.2 billion in 2017 and is anticipated to grow at a CAGR of 19.4% during the forecast period. Cell isolation is the procedure for isolating a single type of cell or multiple type of cell from heterogeneous by routine diagnosis and treatment. Cell therapy separation mainly depends upon the properties of the cells. The most common used technique for cell isolation/cell separation is classified on the basis of adherence, morphology and antibody binding. The recent improvements in cell isolation procedure majorly depends upon the viability of the cells.
The global cell isolation/cell separation market is majorly driven by the growing access to the personal medication for treating diseases, and widespread routine awareness for cell research in the emerging economies. Moreover, with the aim of delivering effective treatment for incurable diseases, the governments are focusing on the new resolution of strengthening research & development. Factors such as increasing number of products similar to the generic medication in the market, and increasing awareness for cell research in the developing economies like India, and China.
North America Cell Isolation Market Share, By Cell Type, 2017 - 2025
Note: Inside circle depicts data for 2017 & outside circle depicts data for 2025
The global cell isolation/cell separation market is segmented on the basis of by products (Consumables (Reagents & Kits, Beads, Disposables), Instruments (Magnetic Activated cell Separated, Filtration System, Centrifuge, Flow Cytometers)), by technique (Centrifugation, Surface Marker, Filtration), by cell type (Human Cell Type (Differentiated Cells, Stem Cells), Animals cells), By Application (Biomolecule Isolation, Therapeutics, Cancer Research, In Vitro Diagnostics, Stem Cell Research), by end use (Research Laboratories, Cell Banks, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostics Laboratories). The report analyzes the global market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Geographically, North America accounted for the largest share in the global cell isolation/cell separation market in 2017.
North America Cell Isolation Market, By Cell Type, 2017 - 2025 (USD Billion)
The global cell isolation/cell separation market on the basis of geography is segmented as North America, Europe, Latin America, and Middle East and Africa. Regionally, North America holds the major market share in the cell isolation market. This market growth is primarily driven by the factors are improved healthcare infrastructure with a focus on cancer research, and organized regional structure for regulating and supporting the innovation for developing new treatments. Additionally, pool of key players in this region would also spur the market of cell isolation in North America. While, Asia Pacific is considered to be the fastest growing region throughout the forecast period. The primary factors supporting the growth of this market in Asia Pacific are increasing awareness for this method as an effective treatment for various chronic diseases, and favorable government regulations supporting the adoption of cell isolation method would also sour the market in Asia Pacific.
The leading companies operating in this industry include Thermo Fisher Scientific, Inc., BD Biosciences, Beckman Coulter, Inc., Merck & company, GE Healthcare, STEMCELL Technologies Inc., Terumo BCT, Bio-Rad Laboratories Inc., PluriSelect Life Sciences, Sigma-Aldrich Corporation, Clontech Laboratories and Miltenyi BioTec.